MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia

出版年份 2017 全文链接

标题

作者

关键词

MLL, MLL-AF4, DOT1L, H3K79me2, leukemia, epigenetic therapy, drug combination therapy, epigenetic spreading

出版物

Cell Reports

Volume 18, Issue 2, Pages 482-495

出版商

Elsevier BV

发表日期

2017-01-11

DOI

10.1016/j.celrep.2016.12.054

向作者/读者发起求助以获取更多资源

Protocol

在线求助

Reagent

在线求助

Reprint

联系作者

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.